Parents of two infants who fell ill with infantile botulism are suing the manufacturer of ByHeart baby formula, amid a nationwide recall. The babies' conditions worsened rapidly after consuming the formula, leading to lengthy hospitalizations.
Rose Dexter, 4 months old, and Piper Everett, also 4 months old, were among at least 15 infants in a dozen states who contracted the rare disease. Rose's parents had bought ByHeart as an organic alternative to traditional baby formulas, unaware of the potential risk.
The lawsuits claim that ByHeart formula was defective and that the company was negligent in selling it. The families seek financial payment for medical bills, emotional distress, and other harm.
Both infants received treatment with BabyBIG medication, which is typically used for botulism cases in children under a year old. Doctors immediately ordered doses of the medication after Piper showed signs of illness.
The babies' conditions have improved since receiving treatment, but their parents are still grappling with the trauma and concern that their children endured. ByHeart officials said they would address any legal claims in due course.
An investigation into the recall is ongoing, with federal health officials confirming that a sample from an open can of ByHeart formula contained bacteria that can lead to illness. The company sells about 1% of the baby formula purchased in the US, and there is no risk of a formula shortage due to the recall, according to the FDA commissioner.
The families' experiences highlight concerns over food safety and the need for stricter regulations on organic products.
Rose Dexter, 4 months old, and Piper Everett, also 4 months old, were among at least 15 infants in a dozen states who contracted the rare disease. Rose's parents had bought ByHeart as an organic alternative to traditional baby formulas, unaware of the potential risk.
The lawsuits claim that ByHeart formula was defective and that the company was negligent in selling it. The families seek financial payment for medical bills, emotional distress, and other harm.
Both infants received treatment with BabyBIG medication, which is typically used for botulism cases in children under a year old. Doctors immediately ordered doses of the medication after Piper showed signs of illness.
The babies' conditions have improved since receiving treatment, but their parents are still grappling with the trauma and concern that their children endured. ByHeart officials said they would address any legal claims in due course.
An investigation into the recall is ongoing, with federal health officials confirming that a sample from an open can of ByHeart formula contained bacteria that can lead to illness. The company sells about 1% of the baby formula purchased in the US, and there is no risk of a formula shortage due to the recall, according to the FDA commissioner.
The families' experiences highlight concerns over food safety and the need for stricter regulations on organic products.